Page 340 - J7288_con_26_Progr_avanzato_V12

SESSIONI e-POSTER - SABATO 9 MAGGIO

10.00-11.00 - SALA DELLA PIAZZA

CARDIOLOGIA CLINICA – DIABETE Pannello B
(S2867)

Moderatore: Vito Altamura-(Roma)

P350 - COMPARATIVE 12-MONTH CARDIOMETABOLIC: IMPACT OF SEMAGLUTIDE VS
TIRZEPATIDE: A SYNTHETIC PROPENSITY-MATCHED ANALYSIS
G. Fazio
Casa di Cura Triolo Zancla, Palermo

P351 - IMPROVEMENTS IN CARDIOMETABOLIC RISK FACTORS BY BODY WEIGHT
REDUCTION WITH TIRZEPATIDE IN ADULTS WITH OBESITY AND PREDIABETES: A POST HOC
ANALYSIS OF THE 3-YEAR SURMOUNT-1 STUDY
D. Della Riva, L. Laffin,-N. Sattar,-B. Linetzky,-A. Plat,-H. Wang,-A. Stefanski,-C. Gerber
Ospedale Bellaria, Bologna; Section of Preventive Cardiology And Rehabilitation, Department
of Cardiovascular Medicine, Cleveland; Institute of Cardiovascular And Medical Sciences, Bhf Glasgow Cardiovascular Research
Centre, University of Glasgow, Glasgow; Eli Lilly And Company, Indianapolis; Eli Lilly And Company, Indianapolis; Techdata Service
Company, King of Prussia; Eli Lilly And Company, Indianapolis; Eli Lilly And Company, Indianapolis

P352 - TIRZEPATIDE TREATMENT AND ACHIEVING WEIGHT REDUCTION >5%, SBP
REDUCTION >5 MMHG AND NON-HDL CHOLESTEROL REDUCTION >10%: A POST-HOC
ANALYSIS FROM THE SURMOUNT-1 3-YEAR TRIAL
C. Radesich,-N. Sattar,-C. Le Roux,-M. Mamas,-H. Wang,-C. Mast,-G. Dimitriadis,-C. Lee,-A. Plat
Institute of Cardiovascular and Medical Sciences, Bhf Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow;
Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin, Ireland and Diabetes Research Centre,
Ulster University, Coleraine; School of Medicine, Keele University, Staffordshire; Eli Lilly And Company, Indianapolis; Eli Lilly And
Company, Indianapolis; Eli Lilly And Company, Indianapolis; Eli Lilly And Company, Indianapolis; Eli Lilly And Company, Indianapolis

P353 - ANGIOGRAPHIC PROFILE AND MANAGEMENT OF CORONARY AND PERIPHERAL
ARTERY DISEASE IN A CARDIO- DIABETOLOGY COHORT: A 1.5 YEAR OBSERVATIONAL
ABSTRACT (MEDICAL)
G. Carpinella,-F. Sessa,-V. Taglialatela,-V. Fioretti,-F. Furbatto,-F. La Rocca,-G. Nicoletti, F. Serino,-
D. D’Andrea,-M. Liguori,-C. Mauro
Aorn Cardarelli, Napoli
P354 - REAL-WORLD IMPLEMENTATION OF AN INTEGRATED CARDIO-DIABETOLOGY
PATHWAY: A 1.5 YEARS EXPERIENCE IN CARDIOVASULAR RISK PROFILING AND
MANAGEMENT
G. Carpinella,-F. Sessa,-V. Taglialatela,-A. Bellis,-F. Cacciapuoti,-F. Furbatto,-F. La Rocca,-F. Serino,-
D. D’Andrea,-M. Liguori, C. Mauro
Aorn Cardarelli, Napoli

340